During the past decade, Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen" #1 collaborator was "BioLineRx, Ltd." with 1 trials as a collaborator and "Halozyme Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen" are "Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma" (1 trials), "Gastric Cancer" (1 trials), "Melanoma" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen" in a lesser frequency.

Most popular intervention types in "Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Cobimetinib" (3 trials), "Placebo" (3 trials), "Leucovorin" (2 trials) and "Oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".